Threo-4-methylmethylphenidate
[CAS# 191790-79-1]

Identification

• Classification: Flavors and spices >> Synthetic spice >> Carboxylic acid and ester perfume >> Aromatic carboxylic acid ester
• Name: Threo-4-methylmethylphenidate
• Synonyms: methyl (2R)-2-(4-methylphenyl)-2-[(2S)-piperidin-2-yl]acetate
• Molecular Formula: C₁₅H₂₁NO₂
• Molecular Weight: 247.33
• CAS Registry Number: 191790-79-1
• SMILES: CC1=CC=C(C=C1)[C@H]([C@@H]2CCCCN2)C(=O)OC

Discovery and Applications

Threo-4-methylmethylphenidate, also known as dexmethylphenidate, is a chemical compound discovered as a result of research into modifying the structure of methylphenidate. Methylphenidate is a central nervous system stimulant commonly used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Threo-4-methylmethylphenidate specifically refers to the enantiomer of methylphenidate that exhibits pharmacological activity. Its discovery marked a significant advancement in pharmacology

One of the primary applications of threo-4-methylmethylphenidate is in the treatment of ADHD. As a central nervous system stimulant, it works by increasing the levels of neurotransmitters such as dopamine and norepinephrine in the brain, which helps to improve attention, focus, and impulse control in individuals with ADHD. Threo-4-methylmethylphenidate offers a more focused pharmacological effect compared to racemic methylphenidate.

Threo-4-methylmethylphenidate is also utilized in the management of narcolepsy, a neurological disorder characterized by excessive daytime sleepiness and sudden episodes of sleep. By promoting wakefulness and alertness, threo-4-methylmethylphenidate helps individuals with narcolepsy to maintain normal sleep-wake cycles and improve daytime functioning. Its stimulant properties counteract the effects of excessive daytime sleepiness.

In addition to its approved medical indications, threo-4-methylmethylphenidate has garnered interest for its potential cognitive-enhancing effects. Some studies suggest that it may improve cognitive function, memory, and executive function in healthy individuals, leading to its off-label use as a "smart drug" or cognitive enhancer.

Threo-4-methylmethylphenidate continues to be a subject of research for its potential applications in other neurological and psychiatric conditions. Studies explore its efficacy and safety in conditions such as depression, anxiety disorders, and cognitive impairment associated with aging or neurodegenerative diseases.

In some cases, threo-4-methylmethylphenidate is used off-label as a performance-enhancing drug, particularly in competitive settings where increased alertness, focus, and stamina are desired. Athletes, students, and professionals may misuse threo-4-methylmethylphenidate to gain a competitive edge or enhance academic and occupational performance.

References

none